GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CRDF · Mar 31, 2025

Cardiff Oncology, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-25-066886General Corporate
Operating cash generation0thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-11737.61% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-46.83% · CORE · NOT_ENOUGH_HISTORY

Operating margin9thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

-13194.50% · CORE · VALID

SBC intensity82thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1252.29% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-5518.74%
Current
-11737.61%
Delta
-6218.87%
Growth Decreased
Previous
39.96%
Current
-46.83%
Delta
-86.79%
Profitability Decreased
Previous
-7123.13%
Current
-13194.50%
Delta
-6071.36%
Sbc Intensity Increased
Previous
696.93%
Current
1252.29%
Delta
555.37%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.